Thomas M. Soloway
Independent DirectorMr. Thomas M. Soloway, also known as Tom, has been Independent Director of Azora Therapeutics, Inc. since November 3, 2026. He serves as an Independent Director of Third Harmonic Bio, Inc. from July 2022. He served as an Independent Director at Satsuma Pharmaceuticals, Inc. since July 2, 2020 until June 8, 2023. He has been Chief Executive Officer and Director at T-Knife GmbH. He served as Chief Operating Officer and Executive Vice President of Audentes Therapeutics, Inc. until 2020. Mr. Soloway served as a senior member of the executive team of Audentes Therapeutics, Inc since October 2015 until September 2020. Mr. Soloway co-founded Transcept Pharmaceuticals, Inc. Mr. Soloway held various positions, including Chief Financial Officer and Executive Vice President, Chief Operating Officer at Transcept Pharmaceuticals, Inc., from September 2002 to December 2013. He had been the Chief Financial Officer of Audentes Therapeutics, Inc. since September 2015 until 2020 and served as its Treasurer since January 15, 2020. Mr. Soloway previously served as Senior Vice President of Audentes Therapeutics, Inc. since February 6, 2019. Mr. Soloway has experience in the life sciences industry, with senior roles in strategy, operations, corporate finance and venture capital. He served as the Chief Financial Officer and Senior Vice President of Ascendis Pharma A/S since January 2014 until September 2015 and also served as its Executive Director and Member of Executive Board. He served as the Senior Vice President of Operations at Transcept Pharmaceuticals, Inc. since July 2003 and November 2005, respectively. Prior to joining TPI, he served as Principal Partner at Montreux Equity Partners, Montreux Equity Partners IV, L.P., Montreux Equity Partners II, L.P. and Montreux Equity Partners III, L.P. Prior to, he served as the Chief Financial Officer for RespondTV. Prior to joining Montreux, he managed the start-up of a home medical equipment division at Hi-Tech Healthcare, an entrepreneurial venture dedicated to delivering high quality home health services. Mr. Soloway financed and advised early stage healthcare and life sciences companies as a Principal at Montreux Equity Partners. Mr. Soloway served as a Director of Entelos, Inc. since May 2010. Mr. Soloway holds a Masters of Business Administration from Georgetown University and a Bachelor’s of Science in Entrepreneurial Studies from the University of Southern California.
Positions
- Company NameAzora Therapeutics, Inc.Stock CodeAZRPositionIndependent Director
